HANGHANG
WU
Investigador de proyecto
University Hospital Aachen
Aachen, AlemaniaPublicacions en col·laboració amb investigadors/es de University Hospital Aachen (4)
2023
-
JNKs protect from cholestatic liver disease progression by modulating Apelin signalling
JHEP Reports, Vol. 5, Núm. 11
2022
-
Activation of the unfolded protein response (Upr) is associated with cholangiocellular injury, fibrosis and carcinogenesis in an experimental model of fibropolycystic liver disease
Cancers, Vol. 14, Núm. 1
-
Genetic and pharmacological inhibition of XBP1 protects against APAP hepatotoxicity through the activation of autophagy
Cell death & disease, Vol. 13, Núm. 2, pp. 143
2021
-
Fibrotic events in the progression of cholestatic liver disease
Cells, Vol. 10, Núm. 5